Now recruiting sites globally

Now selecting sites for our Phase II IBD trial!

Next-Generation Pharma Company

Focused on advancing a pipeline of potentially best-in-class biologics and RNA therapeutics across areas of unmet need

Our model is powered by a computational discovery engine and highly automated clinical trials

Computationally Enabled Discovery.

Computationally enabled discovery platform delivers programs with best-in-class, differentiated profiles at-scale.

Automated Clinical Trials.

Leveraging technology to automate clinical trials, enhancing precision and efficiency in drug development.

Recent Updates

Press Releases

Vial Announces Dosing of First Participants in Phase 1 Healthy Volunteer Trial of a Novel Subcutaneous Half-Life Extended Anti-TL1A Antibody for the Treatment of IBD and Other Inflammatory and Fibrotic Diseases

Press Releases

Vial Initiating Phase 1 Healthy Volunteer Trial of VIAL-TL1A-HLE, a Novel Subcutaneous Half-Life Extended Anti-TL1A Antibody for the Treatment of IBD and Other Inflammatory and Fibrotic Diseases

Stay updated on recent news and upcoming events.

http://Group%20of%20people%20smiling%20wearing%20aprons

http://People%20posing%20for%20group%20picture%20after%20playing%20pickleball.

http://Man%20talking%20into%20microphone

http://Group%20of%20smiling%20people%20posing%20for%20a%20picture

Open Positions

Join our team in reimagining drug development.

Explore Roles